A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

Status:
Completed

Trial end date:
2017-12-18

Target enrollment:

Participant gender:

This study will assess the pharmacodynamic effects of SAGE-217 in approximately 42 healthy adult subjects using an insomnia model.

Phase 1

Sage Therapeutics